Abbott Laboratories has launched its Xience Prime drug-eluting coronary stent system in Europe and in select countries in Asia-Pacific and Latin America.
The Abbott Park, IL-based firm received the European CE Mark for Xience Prime in June. Xience Prime is not yet available in the U.S.
Related Reading
Medtronic, Abbott bury patent-dispute hatchet, July 27, 2009
Abbott begins U.S. trial of Absolute Pro stent, April 1, 2009
Abbott gets FDA nod for Xience V, July 3, 2008
U.S. panel backs Abbott's drug-coated heart stent, December 3, 2007
Copyright © 2009 AuntMinnie.com